Avalanche Biotech

Avalanche Biotech

Avalanche Biotech

Avalanche develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat ophthalmologic disorders.
Founded
2006
Raised
$65M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$9,999,995
Venture capital - 2014
$55,000,000
Venture capital (Series B) - 2014
Redmile Group Adage Capital Management Venrock +3
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Avalanche Biotech makes some noise.